Etienne Morel’s talk at ITMO Cell Biology (Aviesan)
Etienne Morel, collaborator of ENYO Pharma, gave a talk describing the results of our collaboration entitled: “Mitochondrial morphodynamics and ER-mitochondria membrane crosstalk in antiviral innate immunity” at “ITMO Cell biology, development and evolution” event organized by Aviesan on October the 6th, 2021.
Read next in 'Events'
- The 2024 international workshop on Alport syndrome
- ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
- 6th CKD Summit – Chronic Kidney Disease Drug Development
- ASN Kidney Week
- Alport Connect 2023, the annual Alport syndrome patient and family meeting in US